Figure 1From: TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients CA-125 [kU/L] (A), TIMP-1 [ng/L] (B) and VEGF [pg/L] (C) before and after surgery (=before chemotherapy) and during and after chemotherapy (Wilcoxon Tests comparing paired samples at successive time points for individual patients).Back to article page